- Home
- APLT vs TIXT Comparison
APLT vs TIXT Comparison
Compare APLT & TIXT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- APLT
- TIXT
- Stock Information
- Founded
- APLT 2016
- TIXT 2005
- Country
- APLT United States
- TIXT Canada
- Employees
- APLT N/A
- TIXT N/A
- Industry
- APLT Biotechnology: Pharmaceutical Preparations
- TIXT EDP Services
- Sector
- APLT Health Care
- TIXT Technology
- Exchange
- APLT Nasdaq
- TIXT Nasdaq
- Market Cap
- APLT 44.0M
- TIXT 812.7M
- IPO Year
- APLT 2019
- TIXT 2021
- Fundamental
- Price
- APLT $0.41
- TIXT $3.76
- Analyst Decision
- APLT Buy
- TIXT Hold
- Analyst Count
- APLT 7
- TIXT 9
- Target Price
- APLT $6.10
- TIXT $4.17
- AVG Volume (30 Days)
- APLT 2.6M
- TIXT 1.3M
- Earning Date
- APLT 08-06-2025
- TIXT 08-01-2025
- Dividend Yield
- APLT N/A
- TIXT N/A
- EPS Growth
- APLT N/A
- TIXT N/A
- EPS
- APLT N/A
- TIXT N/A
- Revenue
- APLT $265,000.00
- TIXT $2,671,000,000.00
- Revenue This Year
- APLT $1,768.13
- TIXT $3.61
- Revenue Next Year
- APLT $292.85
- TIXT $3.59
- P/E Ratio
- APLT N/A
- TIXT N/A
- Revenue Growth
- APLT N/A
- TIXT N/A
- 52 Week Low
- APLT $0.30
- TIXT $2.13
- 52 Week High
- APLT $10.62
- TIXT $6.86
- Technical
- Relative Strength Index (RSI)
- APLT 58.87
- TIXT 66.56
- Support Level
- APLT $0.32
- TIXT $3.55
- Resistance Level
- APLT $0.36
- TIXT $3.92
- Average True Range (ATR)
- APLT 0.04
- TIXT 0.10
- MACD
- APLT 0.01
- TIXT -0.01
- Stochastic Oscillator
- APLT 94.92
- TIXT 60.71
About APLT Applied Therapeutics Inc.
Applied Therapeutics Inc is a clinical-stage biopharmaceutical company, developing a pipeline of novel product candidates against validated molecular targets in indications of high unmet medical need. The company's drug compounds pipeline includes AT-007 which is a novel central nervous system, penetrant ARI that it is developing for the treatment of rare metabolic diseases, including Galactosemia and Sorbitol Dehydrogenase (SORD) Deficiency, AT-001 for the treatment of diabetic cardiomyopathy, and AT-003 for the treatment of diabetic retinopathy.
About TIXT TELUS International (Cda) Inc. Subordinate Voting Shares
TELUS International (Cda) Inc is a digital customer experience innovator that designs, builds, and delivers next-generation solutions. Its clients include companies across several verticals, including Tech and Games, eCommerce and FinTech, Banking, Financial Services and Insurance, Communications and Media, and Healthcare. The solutions offered by the company include Digital Experience, Customer Experience, Advisory Services, and Back Office and Automation among other services. Geographically, it derives a majority of its revenue from the European region.